DGX
Quest Diagnostics Incorporated
Price Chart
Latest Quote
$195.00
-2.76 (-1.40%)
Current Price
| Previous Close | $197.76 |
| Open | $196.69 |
| Day High | $197.44 |
| Day Low | $192.83 |
| Volume | 677,784 |
Stock Information
| Quarterly Dividend / Yield | $3.44 / 1.76% |
| Shares Outstanding | 110.70M |
| Quarterly Dividend Yield | 1.76% |
| Quarterly Dividend | $3.44 |
| Total Debt | $6.41B |
| Cash Equivalents | $393.00M |
| Revenue | $11.28B |
| Net Income | $1.02B |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $21.59B |
| P/E Ratio | 21.55 |
| EPS (TTM) | $9.05 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $27.98B |
| Sales | $11.28B |
| Income | $1.02B |
| Book/sh | $66.36 |
| Cash/sh | $3.55 |
| Employees | 57K |
Financial Ratios
| Quick Ratio | 0.91 |
| Current Ratio | 1.18 |
| Debt/Eq | 82.74 |
| EPS Growth TTM | 14.50% |
Returns & Margins
| ROA | 6.35% |
| ROE | 14.54% |
| Gross Margin | 33.28% |
| Operating Margin | 14.20% |
| Profit Margin | 9.08% |
Ownership
| Insider Ownership | 0.43% |
| Institutional Ownership | 97.88% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 16.71 |
| PEG | 1.50 |
| P/S | 1.91 |
| P/B | 2.94 |
Analyst Data
| Recommendation | buy |
| Target Price | $223.44 |
Technical Indicators
| SMA20 | $197.54 |
| SMA50 | $194.86 |
| SMA200 | $188.52 |
| RSI | 50.16 |
| ATR | 4.7807 |
| Shares Float | 110.08M |
| Short Float | 3.11% |
| Short Ratio | 4.19 |
| Volatility | 0.59 |
| Rel Volume | 1.55 |
Performance History
| Week | -4.33% |
| Month | +2.42% |
| Quarter | +0.87% |
| 6 Months | +10.12% |
| YTD | +13.21% |
| Year | +10.93% |
| 3 Years | +51.43% |
| 5 Years | +68.93% |
| 10 Years | +205.55% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $195.00 | 1,292,200 |
| 2026-06-17 | $197.76 | 754,200 |
| 2026-06-16 | $201.04 | 1,020,300 |
| 2026-06-15 | $202.18 | 1,009,300 |
| 2026-06-12 | $203.06 | 898,800 |
| 2026-06-11 | $203.83 | 1,079,900 |
| 2026-06-10 | $203.78 | 786,600 |
| 2026-06-09 | $204.53 | 747,100 |
| 2026-06-08 | $197.21 | 821,700 |
| 2026-06-05 | $200.29 | 816,200 |
| 2026-06-04 | $196.12 | 735,900 |
| 2026-06-03 | $193.67 | 648,100 |
| 2026-06-02 | $193.16 | 678,300 |
| 2026-06-01 | $192.20 | 609,500 |
| 2026-05-29 | $194.90 | 1,264,300 |
| 2026-05-28 | $196.20 | 653,700 |
| 2026-05-27 | $193.99 | 597,200 |
| 2026-05-26 | $192.88 | 869,400 |
| 2026-05-22 | $195.21 | 871,300 |
| 2026-05-21 | $193.82 | 474,000 |
| 2026-05-20 | $193.75 | 948,700 |
| 2026-05-19 | $190.39 | 794,600 |
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
đ° Latest News
Is Quest Diagnostics Stock Underperforming the S&P 500?
Barchart âĸ 2026-06-19T03:11:58Z
Is Labcorp Holdings Stock Underperforming the Nasdaq?
Barchart âĸ 2026-06-18T13:31:44Z
Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, LifeStance Health and Aveanna Healthcare
Zacks âĸ 2026-06-10T13:22:00Z
4 Outpatient Home Health Stocks Benefiting From Industry Trends
Zacks âĸ 2026-06-09T14:40:00Z
How The Quest Diagnostics (DGX) Investment Story Is Evolving Without New Analyst Price Target Changes
Simply Wall St. âĸ 2026-06-04T17:08:10Z
DaVita HealthCare (DVA) Up 0.6% Since Last Earnings Report: Can It Continue?
Zacks âĸ 2026-06-04T15:30:12Z
Encompass Health to Expand WV Footprint With 36-Bed Bridgeport Unit
Zacks âĸ 2026-06-01T12:09:00Z
Quest Diagnostics (DGX) Upgraded to Buy: Here's What You Should Know
Zacks âĸ 2026-05-29T16:00:04Z
3 Reasons to Sell DGX and 1 Stock to Buy Instead
StockStory âĸ 2026-05-28T17:26:27Z
Are Medical Stocks Lagging Quest Diagnostics (DGX) This Year?
Zacks âĸ 2026-05-26T13:40:01Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $6,954,000,000 | $6,262,000,000 | $5,868,000,000 | $6,133,000,000 |
| Cost Of Revenue | $7,370,000,000 | $6,628,000,000 | $6,199,000,000 | $6,450,000,000 |
| Total Revenue | $11,035,000,000 | $9,872,000,000 | $9,252,000,000 | $9,883,000,000 |
| Operating Revenue | $11,035,000,000 | $9,872,000,000 | $9,252,000,000 | $9,883,000,000 |
| Expenses | ||||
| Interest Expense | $277,000,000 | $226,000,000 | $163,000,000 | $148,000,000 |
| Total Expenses | $9,479,000,000 | $8,526,000,000 | $7,990,000,000 | $8,455,000,000 |
| Other Income Expense | $26,000,000 | $30,000,000 | $20,000,000 | $-55,000,000 |
| Other Non Operating Income Expenses | $26,000,000 | $30,000,000 | $20,000,000 | $-55,000,000 |
| Net Non Operating Interest Income Expense | $-264,000,000 | $-201,000,000 | $-152,000,000 | $-138,000,000 |
| Interest Expense Non Operating | $277,000,000 | $226,000,000 | $163,000,000 | $148,000,000 |
| Operating Expense | $2,109,000,000 | $1,898,000,000 | $1,791,000,000 | $2,005,000,000 |
| Other Operating Expenses | $-12,000,000 | $1,000,000 | $41,000,000 | $11,000,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $992,000,000 | $871,000,000 | $854,000,000 | $946,000,000 |
| Net Interest Income | $-264,000,000 | $-201,000,000 | $-152,000,000 | $-138,000,000 |
| Interest Income | $13,000,000 | $25,000,000 | $11,000,000 | $10,000,000 |
| Normalized Income | $992,000,000 | $871,000,000 | $854,000,000 | $946,000,000 |
| Net Income From Continuing And Discontinued Operation | $992,000,000 | $871,000,000 | $854,000,000 | $946,000,000 |
| Total Operating Income As Reported | $1,556,000,000 | $1,346,000,000 | $1,262,000,000 | $1,428,000,000 |
| Net Income Common Stockholders | $988,000,000 | $866,000,000 | $850,000,000 | $942,000,000 |
| Net Income | $992,000,000 | $871,000,000 | $854,000,000 | $946,000,000 |
| Net Income Including Noncontrolling Interests | $1,046,000,000 | $921,000,000 | $908,000,000 | $1,015,000,000 |
| Net Income Continuous Operations | $1,046,000,000 | $921,000,000 | $908,000,000 | $1,015,000,000 |
| Earnings From Equity Interest Net Of Tax | $42,000,000 | $19,000,000 | $26,000,000 | $44,000,000 |
| Pretax Income | $1,318,000,000 | $1,175,000,000 | $1,130,000,000 | $1,235,000,000 |
| Interest Income Non Operating | $13,000,000 | $25,000,000 | $11,000,000 | $10,000,000 |
| Operating Income | $1,556,000,000 | $1,346,000,000 | $1,262,000,000 | $1,428,000,000 |
| Depreciation Amortization Depletion Income Statement | $154,000,000 | $127,000,000 | $108,000,000 | $120,000,000 |
| Depreciation And Amortization In Income Statement | $154,000,000 | $127,000,000 | $108,000,000 | $120,000,000 |
| Amortization Of Intangibles Income Statement | $154,000,000 | $127,000,000 | $108,000,000 | $120,000,000 |
| Gross Profit | $3,665,000,000 | $3,244,000,000 | $3,053,000,000 | $3,433,000,000 |
| Net Income Discontinuous Operations | - | - | - | - |
| Per Share | ||||
| Diluted EPS | $8.75 | $7.69 | $7.49 | $7.97 |
| Basic EPS | $8.87 | $7.78 | $7.59 | $8.10 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $2,165,000,000 | $1,894,000,000 | $1,732,000,000 | $1,820,000,000 |
| Reconciled Depreciation | $570,000,000 | $493,000,000 | $439,000,000 | $437,000,000 |
| EBITDA (Bullshit earnings) | $2,165,000,000 | $1,894,000,000 | $1,732,000,000 | $1,820,000,000 |
| EBIT | $1,595,000,000 | $1,401,000,000 | $1,293,000,000 | $1,383,000,000 |
| Diluted Average Shares | $113,000,000 | $113,000,000 | $113,000,000 | $118,000,000 |
| Basic Average Shares | $111,000,000 | $111,000,000 | $112,000,000 | $116,000,000 |
| Diluted NI Availto Com Stockholders | $988,000,000 | $866,000,000 | $850,000,000 | $942,000,000 |
| Otherunder Preferred Stock Dividend | $4,000,000 | $5,000,000 | $4,000,000 | $4,000,000 |
| Minority Interests | $-54,000,000 | $-50,000,000 | $-54,000,000 | $-69,000,000 |
| Tax Provision | $314,000,000 | $273,000,000 | $248,000,000 | $264,000,000 |
| Amortization | $154,000,000 | $127,000,000 | $108,000,000 | $120,000,000 |
| Selling General And Administration | $1,967,000,000 | $1,770,000,000 | $1,642,000,000 | $1,874,000,000 |
Fetched: 2026-06-12
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-3,411,000,000 | $-3,841,000,000 | $-2,592,000,000 | $-2,419,000,000 |
| Total Assets | $16,225,000,000 | $16,153,000,000 | $14,022,000,000 | $12,837,000,000 |
| Other Non Current Assets | $270,000,000 | $255,000,000 | $198,000,000 | $144,000,000 |
| Goodwill And Other Intangible Assets | $10,581,000,000 | $10,619,000,000 | $8,899,000,000 | $8,312,000,000 |
| Other Intangible Assets | $1,636,000,000 | $1,763,000,000 | $1,166,000,000 | $1,092,000,000 |
| Current Assets | $2,378,000,000 | $2,392,000,000 | $2,372,000,000 | $1,898,000,000 |
| Other Current Assets | $361,000,000 | $351,000,000 | $286,000,000 | $196,000,000 |
| Inventory | $189,000,000 | $188,000,000 | $190,000,000 | $192,000,000 |
| Receivables | $1,408,000,000 | $1,304,000,000 | $1,210,000,000 | $1,195,000,000 |
| Accounts Receivable | $1,408,000,000 | $1,304,000,000 | $1,210,000,000 | $1,195,000,000 |
| Allowance For Doubtful Accounts Receivable | $-25,000,000 | $-29,000,000 | $-27,000,000 | $-30,000,000 |
| Gross Accounts Receivable | $1,433,000,000 | $1,333,000,000 | $1,237,000,000 | $1,225,000,000 |
| Cash Cash Equivalents And Short Term Investments | $420,000,000 | $549,000,000 | $686,000,000 | $315,000,000 |
| Cash And Cash Equivalents | $420,000,000 | $549,000,000 | $686,000,000 | $315,000,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $5,454,000,000 | $5,830,000,000 | $4,156,000,000 | $3,757,000,000 |
| Total Debt | $6,585,000,000 | $7,087,000,000 | $5,498,000,000 | $4,714,000,000 |
| Long Term Debt And Capital Lease Obligation | $5,704,000,000 | $6,150,000,000 | $4,913,000,000 | $4,467,000,000 |
| Long Term Debt | $5,167,000,000 | $5,615,000,000 | $4,410,000,000 | $3,978,000,000 |
| Current Debt And Capital Lease Obligation | $881,000,000 | $937,000,000 | $585,000,000 | $247,000,000 |
| Current Debt | $707,000,000 | $764,000,000 | $432,000,000 | $94,000,000 |
| Other Current Borrowings | $504,000,000 | $602,000,000 | $303,000,000 | $2,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $8,939,000,000 | $9,257,000,000 | $7,604,000,000 | $6,830,000,000 |
| Total Non Current Liabilities Net Minority Interest | $6,661,000,000 | $7,088,000,000 | $5,789,000,000 | $5,279,000,000 |
| Other Non Current Liabilities | $957,000,000 | $938,000,000 | $876,000,000 | $812,000,000 |
| Current Liabilities | $2,278,000,000 | $2,169,000,000 | $1,815,000,000 | $1,551,000,000 |
| Payables And Accrued Expenses | $1,397,000,000 | $1,232,000,000 | $1,230,000,000 | $1,304,000,000 |
| Interest Payable | $25,000,000 | $31,000,000 | $64,000,000 | $26,000,000 |
| Payables | $465,000,000 | $376,000,000 | $462,000,000 | $423,000,000 |
| Other Payable | $51,000,000 | $5,000,000 | $5,000,000 | $23,000,000 |
| Dividends Payable | $89,000,000 | $84,000,000 | $79,000,000 | $74,000,000 |
| Total Tax Payable | $18,000,000 | $0 | $0 | $2,000,000 |
| Income Tax Payable | $18,000,000 | $0 | $0 | $2,000,000 |
| Accounts Payable | $307,000,000 | $287,000,000 | $378,000,000 | $324,000,000 |
| Equity | ||||
| Common Stock Equity | $7,170,000,000 | $6,778,000,000 | $6,307,000,000 | $5,893,000,000 |
| Total Equity Gross Minority Interest | $7,286,000,000 | $6,896,000,000 | $6,418,000,000 | $6,007,000,000 |
| Stockholders Equity | $7,170,000,000 | $6,778,000,000 | $6,307,000,000 | $5,893,000,000 |
| Gains Losses Not Affecting Retained Earnings | $-27,000,000 | $-88,000,000 | $-14,000,000 | $-21,000,000 |
| Other Equity Adjustments | $-27,000,000 | $-88,000,000 | $-14,000,000 | $-21,000,000 |
| Retained Earnings | $9,994,000,000 | $9,360,000,000 | $8,825,000,000 | $8,290,000,000 |
| Long Term Equity Investment | $136,000,000 | $123,000,000 | $135,000,000 | $132,000,000 |
| Preferred Securities Outside Stock Equity | - | - | - | - |
| Other | ||||
| Treasury Shares Number | $52,000,000 | $51,000,000 | $51,000,000 | $51,000,000 |
| Ordinary Shares Number | $110,242,362 | $110,615,181 | $111,434,997 | $111,000,000 |
| Share Issued | $162,242,362 | $161,615,181 | $162,434,997 | $162,000,000 |
| Tangible Book Value | $-3,411,000,000 | $-3,841,000,000 | $-2,592,000,000 | $-2,419,000,000 |
| Invested Capital | $13,044,000,000 | $13,157,000,000 | $11,149,000,000 | $9,965,000,000 |
| Working Capital | $100,000,000 | $223,000,000 | $557,000,000 | $347,000,000 |
| Capital Lease Obligations | $711,000,000 | $708,000,000 | $656,000,000 | $642,000,000 |
| Total Capitalization | $12,337,000,000 | $12,393,000,000 | $10,717,000,000 | $9,871,000,000 |
| Minority Interest | $116,000,000 | $118,000,000 | $111,000,000 | $114,000,000 |
| Treasury Stock | $5,180,000,000 | $4,857,000,000 | $4,826,000,000 | $4,673,000,000 |
| Additional Paid In Capital | $2,381,000,000 | $2,361,000,000 | $2,320,000,000 | $2,295,000,000 |
| Capital Stock | $2,000,000 | $2,000,000 | $2,000,000 | $2,000,000 |
| Common Stock | $2,000,000 | $2,000,000 | $2,000,000 | $2,000,000 |
| Long Term Capital Lease Obligation | $537,000,000 | $535,000,000 | $503,000,000 | $489,000,000 |
| Current Capital Lease Obligation | $174,000,000 | $173,000,000 | $153,000,000 | $153,000,000 |
| Line Of Credit | $203,000,000 | $162,000,000 | $129,000,000 | $92,000,000 |
| Current Accrued Expenses | $932,000,000 | $856,000,000 | $768,000,000 | $881,000,000 |
| Investments And Advances | $136,000,000 | $123,000,000 | $135,000,000 | $132,000,000 |
| Goodwill | $8,945,000,000 | $8,856,000,000 | $7,733,000,000 | $7,220,000,000 |
| Net PPE | $2,860,000,000 | $2,764,000,000 | $2,418,000,000 | $2,351,000,000 |
| Accumulated Depreciation | $-3,973,000,000 | $-3,658,000,000 | $-3,416,000,000 | $-3,337,000,000 |
| Gross PPE | $6,833,000,000 | $6,422,000,000 | $5,834,000,000 | $5,688,000,000 |
| Leases | $894,000,000 | $881,000,000 | $827,000,000 | $760,000,000 |
| Construction In Progress | $252,000,000 | $235,000,000 | $248,000,000 | $277,000,000 |
| Other Properties | $657,000,000 | $651,000,000 | $602,000,000 | $585,000,000 |
| Machinery Furniture Equipment | $4,317,000,000 | $3,964,000,000 | $3,604,000,000 | $3,503,000,000 |
| Buildings And Improvements | $629,000,000 | $610,000,000 | $513,000,000 | $520,000,000 |
| Land And Improvements | $84,000,000 | $81,000,000 | $40,000,000 | $43,000,000 |
| Properties | $0 | $0 | $0 | $0 |
Fetched: 2026-06-12
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $1,359,000,000 | $909,000,000 | $864,000,000 | $1,314,000,000 |
| Operating Activities | ||||
| Operating Cash Flow | $1,886,000,000 | $1,334,000,000 | $1,272,000,000 | $1,718,000,000 |
| Cash Flow From Continuing Operating Activities | $1,886,000,000 | $1,334,000,000 | $1,272,000,000 | $1,718,000,000 |
| Operating Gains Losses | - | - | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-527,000,000 | $-425,000,000 | $-408,000,000 | $-404,000,000 |
| Investing Cash Flow | $-631,000,000 | $-2,548,000,000 | $-1,061,000,000 | $-543,000,000 |
| Cash Flow From Continuing Investing Activities | $-631,000,000 | $-2,548,000,000 | $-1,061,000,000 | $-543,000,000 |
| Net Other Investing Changes | $-3,000,000 | $41,000,000 | $-42,000,000 | $5,000,000 |
| Capital Expenditure Reported | $-527,000,000 | $-425,000,000 | $-408,000,000 | $-404,000,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-450,000,000 | $-151,000,000 | $-275,000,000 | $-1,408,000,000 |
| Financing Cash Flow | $-1,388,000,000 | $1,084,000,000 | $160,000,000 | $-1,732,000,000 |
| Cash Flow From Continuing Financing Activities | $-1,388,000,000 | $1,084,000,000 | $160,000,000 | $-1,732,000,000 |
| Net Other Financing Charges | $-62,000,000 | $-50,000,000 | $-71,000,000 | $-140,000,000 |
| Cash Dividends Paid | $-353,000,000 | $-331,000,000 | $-314,000,000 | $-305,000,000 |
| Common Stock Dividend Paid | $-353,000,000 | $-331,000,000 | $-314,000,000 | $-305,000,000 |
| Net Common Stock Issuance | $-450,000,000 | $-151,000,000 | $-275,000,000 | $-1,408,000,000 |
| Other | ||||
| Repayment Of Debt | $-1,012,000,000 | $-303,000,000 | $-1,844,000,000 | $-2,000,000 |
| Issuance Of Debt | $410,000,000 | $1,846,000,000 | $2,592,000,000 | $0 |
| Interest Paid Supplemental Data | $280,000,000 | $262,000,000 | $134,000,000 | $156,000,000 |
| Income Tax Paid Supplemental Data | $169,000,000 | $256,000,000 | $317,000,000 | $283,000,000 |
| End Cash Position | $420,000,000 | $549,000,000 | $686,000,000 | $315,000,000 |
| Beginning Cash Position | $549,000,000 | $686,000,000 | $315,000,000 | $872,000,000 |
| Effect Of Exchange Rate Changes | $4,000,000 | $-7,000,000 | $0 | $0 |
| Changes In Cash | $-133,000,000 | $-130,000,000 | $371,000,000 | $-557,000,000 |
| Proceeds From Stock Option Exercised | $79,000,000 | $73,000,000 | $72,000,000 | $123,000,000 |
| Common Stock Payments | $-450,000,000 | $-151,000,000 | $-275,000,000 | $-1,408,000,000 |
| Net Issuance Payments Of Debt | $-602,000,000 | $1,543,000,000 | $748,000,000 | $-2,000,000 |
| Net Long Term Debt Issuance | $-602,000,000 | $1,543,000,000 | $748,000,000 | $-2,000,000 |
| Long Term Debt Payments | $-1,012,000,000 | $-303,000,000 | $-1,844,000,000 | $-2,000,000 |
| Long Term Debt Issuance | $410,000,000 | $1,846,000,000 | $2,592,000,000 | $0 |
| Net Business Purchase And Sale | $-101,000,000 | $-2,164,000,000 | $-611,000,000 | $-144,000,000 |
| Purchase Of Business | $-101,000,000 | $-2,164,000,000 | $-611,000,000 | $-144,000,000 |
| Change In Working Capital | $50,000,000 | $-201,000,000 | $-145,000,000 | $119,000,000 |
| Change In Other Working Capital | $3,000,000 | $-79,000,000 | $-73,000,000 | $53,000,000 |
| Change In Payables And Accrued Expense | $153,000,000 | $-51,000,000 | $-57,000,000 | $-180,000,000 |
| Change In Payable | $153,000,000 | $-51,000,000 | $-57,000,000 | $-180,000,000 |
| Change In Account Payable | $129,000,000 | $-67,000,000 | $-55,000,000 | $-149,000,000 |
| Change In Tax Payable | $24,000,000 | $16,000,000 | $-2,000,000 | $-31,000,000 |
| Change In Income Tax Payable | $24,000,000 | $16,000,000 | $-2,000,000 | $-31,000,000 |
| Change In Receivables | $-106,000,000 | $-71,000,000 | $-15,000,000 | $246,000,000 |
| Changes In Account Receivables | $-106,000,000 | $-71,000,000 | $-15,000,000 | $246,000,000 |
| Other Non Cash Items | $24,000,000 | $15,000,000 | $41,000,000 | $66,000,000 |
| Stock Based Compensation | $88,000,000 | $88,000,000 | $77,000,000 | $77,000,000 |
| Provisionand Write Offof Assets | $3,000,000 | $5,000,000 | $1,000,000 | $3,000,000 |
| Deferred Tax | $105,000,000 | $13,000,000 | $-49,000,000 | $1,000,000 |
| Deferred Income Tax | $105,000,000 | $13,000,000 | $-49,000,000 | $1,000,000 |
| Depreciation Amortization Depletion | $570,000,000 | $493,000,000 | $439,000,000 | $437,000,000 |
| Depreciation And Amortization | $570,000,000 | $493,000,000 | $439,000,000 | $437,000,000 |
| Amortization Cash Flow | $154,000,000 | $127,000,000 | $108,000,000 | $120,000,000 |
| Amortization Of Intangibles | $154,000,000 | $127,000,000 | $108,000,000 | $120,000,000 |
| Depreciation | $416,000,000 | $366,000,000 | $331,000,000 | $317,000,000 |
| Net Income From Continuing Operations | $1,046,000,000 | $921,000,000 | $908,000,000 | $1,015,000,000 |
| Net Investment Purchase And Sale | - | - | $-42,000,000 | $5,000,000 |
| Sale Of Business | - | - | $0 | $0 |
| Gain Loss On Sale Of Business | - | - | $0 | $0 |
| Sale Of Investment | - | - | - | $5,000,000 |
| Purchase Of Investment | - | - | - | - |
| Net PPE Purchase And Sale | - | - | - | - |
| Sale Of PPE | - | - | - | - |
| Gain Loss On Sale Of PPE | - | - | - | - |
Fetched: 2026-06-12